Cargando…
COVID-19 vaccine hesitancy in adults with multiple sclerosis in the United States: A follow up survey during the initial vaccine rollout in 2021
BACKGROUND: Multiple sclerosis (MS) organizations have recommended that adults with MS obtain the COVID-19 vaccination. Vaccine hesitancy is a barrier to full COVID-19 inoculation in the general population. Whether vaccine hesitancy is also a barrier towards optimizing vaccination rates in the MS co...
Autores principales: | Ehde, Dawn M., Roberts, Michelle K., Humbert, Andrew T., Herring, Tracy E., Alschuler, Kevin N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295053/ https://www.ncbi.nlm.nih.gov/pubmed/34325399 http://dx.doi.org/10.1016/j.msard.2021.103163 |
Ejemplares similares
-
Willingness to obtain COVID-19 vaccination in adults with multiple sclerosis in the United States
por: Ehde, Dawn M., et al.
Publicado: (2021) -
Distress and risk perception in people living with multiple sclerosis during the early phase of the COVID-19 pandemic
por: Alschuler, Kevin N., et al.
Publicado: (2021) -
COVID-19 vaccine rollout: will it affect the rates of vaccine hesitancy in Africa?
por: Ekwebelem, O.C., et al.
Publicado: (2021) -
COVID-19 Vaccination Rollout: Aspects of Hesitancy in South Africa
por: Steenberg, Bent, et al.
Publicado: (2023) -
Racial/ethnic and nativity disparities in U.S. Covid-19 vaccination hesitancy during vaccine rollout and factors that explain them
por: Frisco, Michelle L., et al.
Publicado: (2022)